Skip to content
DraconiticResearch
Search Sources API
181,713 studies31 sourcesUpdated 15 min ago
Peer-reviewedCC BYJTO clinical and research reports

Brief Report: Reassessment of bTMB as a Predictive Biomarker in NSCLC Immunotherapy—A Reanalysis of OAK and POPLAR

  1. 1Department of Biostatistics and Health Data Science, School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania
  2. 2Department of Biostatistics, School of Public Health, Virginia Commonwealth University, Richmond, Virginia
  3. 3Division of Pulmonary and Critical Care, Virginia Commonwealth University, Richmond, Virginia

Related

  1. Surgical resection for indeterminate pulmonary nodules in patients with prior breast cancer: diagnostic value and biomarker reassessment
    Journal of thoracic diseasePeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC
  2. No Overall Survival Benefit with Adding Chemotherapy to Immunotherapy in PD-L1 TPS >= 50% NSCLC: An Agent-Stratified Reassessment
    F. Han, J. Wang, S. Shi +2
    medRxivPreprintCC BY-NC-NDFull textOncologymedRxiv
  3. GAN-enhanced digital twins for biomarker-guided cancer immunotherapy and adoptive cell therapy: a mini review
    Jiayu Yang
    Frontiers in medicinePeer-reviewedCC BYFull textGeneral medicineEurope PMC
  4. Heterogeneous nuclear ribonucleoproteins depict a new predictive risk model for ovarian cancer prognosis and immunotherapy
    Dongzhi Hu, Shifan Ren, Yongjing Zhang +2
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textObstetrics, gynaecology & paediatricsCrossref
  5. Lactate as a predictive biomarker and therapeutic target in cardiopulmonary bypass-associated acute kidney injury
    Dinghao Xue, Mingru Zhang, Xinlu Chang +4
    iSciencePeer-reviewedCC BY 4.0Full textGeneral medicineCell PressCrossrefEurope PMC
BibTeX
@article{liu2026brief,
  title = {{Brief Report: Reassessment of bTMB as a Predictive Biomarker in NSCLC Immunotherapy—A Reanalysis of OAK and POPLAR}},
  author = {Jiaqian Liu and Na Bo and Patrick Nana-Sinkam and Ying Ding},
  journal = {JTO clinical and research reports},
  year = {2026},
  month = aug,
  url = {https://europepmc.org/article/PMC/PMC13675807},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Brief Report: Reassessment of bTMB as a Predictive Biomarker in NSCLC Immunotherapy—A Reanalysis of OAK and POPLAR
AU  - Jiaqian Liu
AU  - Na Bo
AU  - Patrick Nana-Sinkam
AU  - Ying Ding
PY  - 2026
DA  - 2026/08/31
JO  - JTO clinical and research reports
UR  - https://europepmc.org/article/PMC/PMC13675807
SN  - 2666-3643
ER  -